References

1. Game F., Jeffcoate W., Tarnow L., Jacobsen JL., Whitham DJ., Harrison EF., Ellender SJ., Fitzsimmons D., Löndahl M., LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked randomized controlled trial. Lancet Diabetes Endocrinology. 2018;6(11):870-878.

2. Löndahl, M., Tarnow, L., Karlsmark, T., Lundquist, R., Nielsen, A. M., Michelsen, M., Jørgensen, B. (2015). Use of an autologous leucocyte and platelet rich fibrin patch on hard-to-heal DFUs: a pilot study. Journal of Wound Care, 24(4), 172–8.

3. Lundquist, Jørgensen, Fagher, Löndahl (2015). 3C Patch™ – an adaptive triple layered autologous platelet and leukocyte rich fibrin patch and its clinical use in the treatment of hard-to-heal diabetic foot ulcers. Poster, Innovations in Wound Healing 2015.

4. Schmidt et al. (2019), “An autologous leukocyte and platelet-rich fibrin patch provides immune cells, cytokines and growth factors relevant for treating diabetic foot ulcers”, Poster, ISDF 2019, The Hague, NL

5. Lundquist R et al. (2013), Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds. Wound Repair and Regeneration 21(1), 66–76